We further illustrated that CDK6 from the cell cycle, EGF from the ERBB signaling pathway, and PDGFA from the MAPK signaling pathway were all upregulated in GBM patients with EGFR amplification (Figure 4D). This evidence concerns the gene PDGFA and glioblastoma.